Cargando…
Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review
INTRODUCTION: We conducted a systematic literature review to assess the utility of liver function assessments for predicting disease prognosis and response to systemic anticancer therapy in patients with advanced hepatocellular carcinoma (aHCC). METHODS: This was a PRISMA-standard review and was reg...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561324/ https://www.ncbi.nlm.nih.gov/pubmed/37817754 http://dx.doi.org/10.1159/000529173 |
_version_ | 1785117898464821248 |
---|---|
author | Vogel, Arndt Kelley, Robin K. Johnson, Philip Merle, Philippe Yau, Thomas Kudo, Masatoshi Meyer, Tim Rimassa, Lorenza |
author_facet | Vogel, Arndt Kelley, Robin K. Johnson, Philip Merle, Philippe Yau, Thomas Kudo, Masatoshi Meyer, Tim Rimassa, Lorenza |
author_sort | Vogel, Arndt |
collection | PubMed |
description | INTRODUCTION: We conducted a systematic literature review to assess the utility of liver function assessments for predicting disease prognosis and response to systemic anticancer therapy in patients with advanced hepatocellular carcinoma (aHCC). METHODS: This was a PRISMA-standard review and was registered with PROSPERO (CRD42021244588). MEDLINE and Embase were systematically searched (March 24, 2021) to identify publications reporting the efficacy and/or safety of systemic anticancer therapy (vs. any/no comparator) in liver-function-defined subgroups in phase 2 or 3 aHCC trials. Screening was completed by a single reviewer, with uncertainties resolved by a second reviewer and/or the authors. English-language full-text articles and congress abstracts were eligible for inclusion. Included publications were described and assessed for risk of bias using the GRADE methodology. RESULTS: Twenty (of 2,579) screened publications were eligible; seven categorized liver function using the albumin-bilirubin system, nine using the Child-Pugh system, four using both. GRADE assessment classified ten, nine, and one publication(s) as reporting moderate-quality, low-quality, and very-low-quality evidence, respectively. Analyses of cross-trial trends of within-exposure arm analyses (active and control) reported a positive relationship between baseline liver function and overall survival and progression-free survival, supporting liver function as a prognostic marker in aHCC. There were also signals for a modest relationship between more preserved baseline liver function and extent of systemic treatment benefit, and with more preserved liver function and lower incidence of safety events. CONCLUSION: This review supports liver function as a prognostic variable in aHCC and highlights the value of a priori stratification of patients by baseline liver function in aHCC trials. The predictive value of liver function warrants further study. Findings were limited by the quality of available data. |
format | Online Article Text |
id | pubmed-10561324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-105613242023-10-10 Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review Vogel, Arndt Kelley, Robin K. Johnson, Philip Merle, Philippe Yau, Thomas Kudo, Masatoshi Meyer, Tim Rimassa, Lorenza Liver Cancer Research Article INTRODUCTION: We conducted a systematic literature review to assess the utility of liver function assessments for predicting disease prognosis and response to systemic anticancer therapy in patients with advanced hepatocellular carcinoma (aHCC). METHODS: This was a PRISMA-standard review and was registered with PROSPERO (CRD42021244588). MEDLINE and Embase were systematically searched (March 24, 2021) to identify publications reporting the efficacy and/or safety of systemic anticancer therapy (vs. any/no comparator) in liver-function-defined subgroups in phase 2 or 3 aHCC trials. Screening was completed by a single reviewer, with uncertainties resolved by a second reviewer and/or the authors. English-language full-text articles and congress abstracts were eligible for inclusion. Included publications were described and assessed for risk of bias using the GRADE methodology. RESULTS: Twenty (of 2,579) screened publications were eligible; seven categorized liver function using the albumin-bilirubin system, nine using the Child-Pugh system, four using both. GRADE assessment classified ten, nine, and one publication(s) as reporting moderate-quality, low-quality, and very-low-quality evidence, respectively. Analyses of cross-trial trends of within-exposure arm analyses (active and control) reported a positive relationship between baseline liver function and overall survival and progression-free survival, supporting liver function as a prognostic marker in aHCC. There were also signals for a modest relationship between more preserved baseline liver function and extent of systemic treatment benefit, and with more preserved liver function and lower incidence of safety events. CONCLUSION: This review supports liver function as a prognostic variable in aHCC and highlights the value of a priori stratification of patients by baseline liver function in aHCC trials. The predictive value of liver function warrants further study. Findings were limited by the quality of available data. S. Karger AG 2023-01-17 /pmc/articles/PMC10561324/ /pubmed/37817754 http://dx.doi.org/10.1159/000529173 Text en Copyright © 2023 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher. |
spellingShingle | Research Article Vogel, Arndt Kelley, Robin K. Johnson, Philip Merle, Philippe Yau, Thomas Kudo, Masatoshi Meyer, Tim Rimassa, Lorenza Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review |
title | Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review |
title_full | Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review |
title_fullStr | Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review |
title_full_unstemmed | Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review |
title_short | Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma: A Systematic Literature Review |
title_sort | predictive and prognostic potential of liver function assessment in patients with advanced hepatocellular carcinoma: a systematic literature review |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561324/ https://www.ncbi.nlm.nih.gov/pubmed/37817754 http://dx.doi.org/10.1159/000529173 |
work_keys_str_mv | AT vogelarndt predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT kelleyrobink predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT johnsonphilip predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT merlephilippe predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT yauthomas predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT kudomasatoshi predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT meyertim predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview AT rimassalorenza predictiveandprognosticpotentialofliverfunctionassessmentinpatientswithadvancedhepatocellularcarcinomaasystematicliteraturereview |